
Fertility treatment and the workplace: ‘It's a hugely personal thing to have to say'
A naturally open person, she did not hesitate to tell her manager and colleagues. In return, she got all the flexibility and understanding she needed over the three rounds of
in vitro fertilisation (IVF)
that it took before her partner, Leanne Doyle, gave birth to their son, Theo, two years ago. On their first attempt, the embryos did not implant; after the second round, she had a miscarriage at 10 weeks.
Murphy's employer, the recruitment company Flexsource, which is part of the CPL group, has since incorporated fertility treatment supports into its 'family building' policies. Five days' leave per year is available for the person physically undergoing the treatment and two days for the supporting partner.
However, recently published research would suggest that employers making specific provisions are still in the minority in Ireland. This is despite one in six adults, according to the World Health Organisation, experiencing infertility, which is defined as a failure to conceive after at least 12 months of regular, unprotected sexual intercourse.
READ MORE
About 80 per cent of people who had undergone IVF said their workplace did not have a fertility policy, according to a Sims IVF survey. Almost all respondents (98 per cent) agreed that treatment had an impact on their emotional wellbeing at work, while 83 per cent said it affected their ability to fulfil their work responsibilities.
At support meetings organised by the
National Infertility Support and Information Group
(NISIG), people often talk about the workplace as being one of the biggest challenges when they are undergoing fertility treatment, says NISIG spokeswoman Caitríona Fitzpatrick.
Fertility treatment involves multiple appointments, sometimes at short notice. In the absence of flexibility or dedicated time off, 'people use annual leave or sick leave and it's really neither of those things', she says. They can feel quite unwell after some of the appointments, particularly egg retrieval. Emotionally they might not feel connected to the workplace at that time, she points out.
Yet employees often struggle in silence, maybe because they perceive it to be a taboo topic, or they fear that declaring they are trying to start a family may harm their career progression. But keeping it secret not only adds to the stress but also runs the risk that altered behaviour in the workplace may be wrongly interpreted, again to their detriment.
NISIG believes that workplace awareness of fertility issues and a policy to support those having treatment is good for employees and employers alike. It welcomes a new guide for Irish companies produced by Sims IVF, entitled Navigating Fertility Treatment in the Workplace.
It's just a hugely personal thing to have to say. It's not a conversation you want to be having until you're ready, and you're in a place where you can do it
—
NISIG spokeswoman Caitríona Fitzpatrick
Sims IVF is one of the approved providers in the HSE IVF funding scheme that was launched in September 2023. Currently, heterosexual couples who meet the required criteria are entitled to one free cycle of IVF – or ICSI (intracytoplasmic sperm injection, ie sperm is injected directly into an egg), or up to three rounds of IUI (intrauterine insemination) treatment. At the end of June, eligibility for this
scheme was extended to couples experiencing 'secondary infertility'
, ie having difficulty conceiving a second child.
However, there is no statutory entitlement to time off work during what is known to be both a physically and psychologically demanding and complex process. 'It is absolutely perverse,' Labour TD Ged Nash told the Dáil in January 2024, 'that we have correctly decided funded IVF is a public good, yet access could be restricted to those who can work flexibly, unless a statutory right to leave to access it is introduced.'
He was speaking on a Labour Party Bill that seeks to give workers the right to leave for fertility treatment as well as early pregnancy loss. It is hardly surprising that the impetus for the Bill came from a workplace predominated by women and where flexibility and short-notice leave is particularly challenging – primary schools. Representations from the Irish National Teachers' Organisation prompted the current Labour leader
Ivana Bacik
, then a senator, to introduce the Organisation of Working Time (Reproductive Health Related Leave) Bill 2021.
Last month, the Minister for Children, Disability and Equality, Norma Foley, when asked by Laois TD William Aird if she would support the implementation of that Bill, simply referred to ongoing research on relevant issues, adding: 'Family leave provisions are kept under review to ensure that they are appropriate to the needs of working parents.'
Since the start of the
HSE's assisted human reproduction treatments (AHR) scheme
, there has been an average of 500 referrals per month to the six public regional fertility hubs. Many of these patients can be managed successfully at the hubs via a range of surgical and/or medical interventions and do not require further advanced tertiary treatment such as IVF.
In 2024, the hubs made a total of 1,470 referrals to one of the eight HSE-authorised AHR providers. This year, 911 referrals had been made up to July 7th, according to the HSE.
Tammy Murphy and Leanne Doyle with their two-year-old son Theo. Photograph: Dara Mac Dónaill
A review of the first 12 months of the scheme (September 2023 to August 2024), found 262 clinical pregnancies were reported by the HSE's fertility hubs. A further 79 couples were discharged with a clinical pregnancy from one of the private AHR providers contracted by the HSE.
[
Eight healthy babies born in UK after IVF using DNA from three people
Opens in new window
]
'It is important to note that relatively few couples had been discharged from a private provider by the end of August 2024, with most of the referred couples still undergoing investigation or treatment,' an HSE spokeswoman adds. 'While it is too soon to have meaningful data, the initial results from the service are in line with expectations.'
Although there is undoubtedly much more openness around assisted reproduction, people still experience stigma, says Fitzpatrick. 'A lot of it is a self-stigma, in that they've kind of judged themselves. All that feeds into an emotional toll,' she says.
People are much more likely to talk about it after they have been successful. 'If it's unsuccessful, or you're going through it, is where people keep it very quiet because I suppose they don't want to build up any kind of expectations and they're still only getting their heads around how to explain what they're doing.'
They may also worry that the mere mention of fertility treatment might have an employer's mind jumping forward to the need for maternity leave, as hypothetical as it might be at that stage. At a time when a couple or individual may be investing thousands of euro in private fertility treatment, she says, the fear that they may be passed over for promotion or, say, leadership on a project, 'just compounds all this emotional stress'.
NISIG spokeswoman Caitríona Fitzpatrick
'It's just a hugely personal thing to have to say. It's not a conversation you want to be having until you're ready, and you're in a place where you can do it.'
Availing of a workplace policy would require a privacy trade-off, with disclosure at some level, but a clearly flagged and supportive path when doing this would help. Fitzpatrick says people would not need to indicate exactly where they were in the process.
There are also challenges for employers in addressing these matters, including accommodating a need for time off at short notice, depending on the nature of the work.
'I think knowledge is power,' says Fitzpatrick. 'If they get to know this area, then they can work with their employees on it. As with lots of other areas like this, if an employee feels supported they become very loyal to that employer and it's very hard to put a price on that.'
NISIG sees people who have left their jobs while undergoing treatment because they felt it was too stressful. 'Or they would take a sabbatical because they could not deal with that other pressure in the background and what they felt was a total lack of understanding.'
Some really good, proactive employers, she says, ask NISIG to talk their HR department through what assisted reproduction involves and its impact on patients. They use that information to inform their own workplace policies.
NISIG would like to see the provision of designated leave led by legislation but, in the meantime, hopes that 'a serious number' of employers will take the need on board 'so that it becomes the norm' to have guidance in the workplace.
[
Ireland far behind other countries for IVF genetic testing, doctors and advocates say
Opens in new window
]
'Lots of employees will check the maternity policy before they start a family; if they're going to start medical treatment, they will look at different policies. It should be the same for fertility treatment.'
Then individuals and couples 'can make their decisions based around knowing', Fitzpatrick adds, 'as opposed to being halfway through their treatment and suddenly feeling like, 'I'm going to have to tell somebody,' and it complicates the whole thing.'
The HR manager at Sims IVF, Niamh Doran, wrote the new guide for employers and fellow HR professionals, drawing on real-life experiences of clients, gathered by last year's survey, to highlight the challenges and offer possible solutions. Fostering open communication is key, she suggests, as is employees being able to trust their line manager or HR team to be understanding.
'It's just going to make people feel less like they're being watched. They won't feel like it's going to stunt their career growth, which I think is the number one concern, particularly for women,' Doran says.
The guide includes a fertility policy template for companies to follow when creating their own policies. 'If there's not those examples out there, it's hard to know where to start. We're hoping that this is a jumping off point and people can then tailor it to their business needs.'
Ibec declined to comment on issues raised in this article.
Employee voices on fertility treatment and the workplace:
'I was told it was likely to not work and [will] have to keep trying, so how am I going to manage so it won't impact on my work?'
'Empathy drastically dropped after the first two rounds. My boss actually rolled his eyes when I said I was doing the fourth round.'
'I can see my employer is already trying to recruit for my role in case I go on maternity leave. This makes me uncomfortable as, depending how my treatment goes, I may never go on maternity leave.'
'I received support from my direct manager; the company overall did not know I was undergoing treatment. There is a need for flexibility around appointments, understanding around absence and general awareness of what the process is.'
'I haven't told them as I feel my team lead won't be happy with it and that might damage the relationship.'
'My management were helpful, but certified IVF pay would have been amazing as you have to use your own sick pay for days off and treatments.'
'[I would have appreciated] greater understanding that there can be several appointments to attend and be flexible around this, ie allow an hour to attend a scan without having to take annual leave.'
Source: 2004 Sims IVF survey
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Irish Times
14 hours ago
- Irish Times
Ireland has potential to become global leader in femtech, report says
Ireland could become a global leader in technology, research and innovation focused on women's health, if the right supports are put in the place, a new report has said. The new report, Femtech in Ireland: The Case for Prioritising Women's Health Research and Innovation, is calling on the Government to prioritise the development of femtech in Ireland, by offering greater supports for femtech research and start-ups, and integrate femtech into national health innovation strategies. Ireland has a strong background in medtech, digital health and pharmaceuticals, but femtech is underdeveloped and underfunded, despite women making up half the population. The report is seeking focused funding calls for women's health research and innovation through State agencies, specific funding to commercialise that research, and the establishment of a femtech lab in a healthcare setting with a fast access to clinicliniciansients, data and a test-bed. READ MORE It s also encouraging researchers, clinicians and academics to investigate conditions that affect women only, differently and disproportionately, highlighting the need for the inclusion of sex and gender analysis in research design. The report, which was produced by Health Innovation Hub Ireland (HIHI), and the Department of Obstetrics and Gynaecology at University College Cork (UCC), says improving support for women's health innovation and entrepreneurship could not only address health inequities, but also offer additional economic potential for Ireland, while also strengthening Ireland's life sciences and technology sectors. 'We need to invest in women's health – not just for equality, but because it's smart research, healthcare, and smart economics. There is a real buzz in the femtech innovation sector in Ireland today, with new ideas and start-ups being developed throughout the country,', said Dr Tanya Mulcahy, Director of HIHI and founder of FemTech Ireland. 'We've supported many of them through HIHI, enabling access to clinicians, patients and researchers. It's a sector that is attracting female founders, and provides a new avenue for young researchers, but it's a sector that needs more support- this report is our call to action.' The femtech sector itself is expected to be worth more than $97 billion by 2030, while closing the women's health gap could give the global economy a $1 trillion boost each year by 2040. It could also help unlock new medical treatments and interventions for the wider population. The sector could also encourage more woman founders into the start-up sector, with more than 75 per cent of femtech companies having a woman founder. Minister for Health Jennifer Carroll MacNeill said the report was an important step toward better care for women across Ireland. 'It supports the work we're already doing through the Women's Health Taskforce and highlights how innovation can help us go even further.' The report was also welcomed by Minister for Enterprise, Tourism and Employment Peter Burke. Ireland's first programme to support innovation in women's health, Femtech@HIHI, was launched two years ago. It has now supported more than 30 Irish start-ups that developing everything from wearable tech to track menopause symptoms, to smarter devices for pelvic health and fertility, all aimed at supporting women's health. 'We are witnessing extraordinary advances in healthcare technology and innovation,' said Professor John R Higgins, principal investigator of Health Innovation Hub Ireland and Professor of Obstetrics and Gynaecology, University College Cork and Cork University Maternity Hospital. 'In women's health however, a long-standing gap in research has meant that these innovations have not always translated into meaningful solutions. This gap in evidence directly impacts the development of technologies. Now is the time to bridge that divide – with focused funding, targeted research, and innovation supports.'


Irish Times
16 hours ago
- Irish Times
‘Natural population' falls in 15 areas, from Belmullet to Dún Laoghaire
There was a fivefold increase in the number of local electoral areas (LEAs) across Ireland in which more deaths than births were recorded in 2022, new figures released by the Central Statistics Office (CSO) show. The majority of the 15 areas in question are rural towns in the west and south of the country, although the list also includes parts of Dublin typically seen to be more affluent than average, such as Rathfarnham-Templeogue and Dún Laoghaire in south Dublin. The figures are contained in a new release from the CSO. The data covers the country's 166 LEAs and shows the largest natural population decline, a measure that excludes inward or outward migration, occurred in Belmullet, Co Mayo with a rate of -2.9. READ MORE The figure is calculated by combining an area's death rate per thousand of population with its birth rate. In Belmullet's case, the -2.9 figure was calculated from of a birth rate of 8.6 and a death rate of 11.5. Other towns with a notably high natural decrease rate were Glenties, Co Donegal (-2.3) and Kenmare, Co Kerry (-1.2). In these areas, an ageing population means death rates are consistently higher than birth rates with Belmullet and Glenties experiencing a decrease for two consecutive years, the CSO records show. The other local areas that experienced a natural decrease in population were Swinford, Co Mayo; Kilrush, Co Clare; Ballinamore, Co Leitrim; Rosslare, Co Wexford; Tralee, Co Kerry; Boyle, Co Roscommon; Ballymote-Tobercurry, Co Sligo; Artane-Whitehall, Dublin; Bantry-West, Co Cork; and Castleisland, Co Kerry. The highest rates of natural increase in population were all in Dublin: Blanchardstown-Mulhuddart and Ongar, both in the Fingal constituency of Dublin, and both with a rate of 9.7, as well as Tallaght South, South Dublin where the rate was 9.6. Nationwide, the CSO statistics show the rate of natural increase of population in 2022 stood at 3.5, with 54,483 births recorded and 35,804 deaths in total. The CSO noted this rate 'varied significantly across LEAs', but that particularly high numbers of births and deaths were seen in urban areas in north Dublin. The CSO data also showed the national birth rate stood at 10.2, with Tallaght South boasting the highest birth rate in the country at 13.7 live births per 1,000 people. Enniscorthy, Co Wexford and Ongar, Fingal in Dublin were the other LEAs with the highest birth rates, at 13.3 and 13.2 respectively. Seán O'Connor, a statistician with the CSO, said the newly released data 'includes population statistics that are entirely based on administrative records, and as this release uses experimental methodology, [the] estimates are not official population statistics and are not comparable with Census of Population data'. The census conducted in 2022 showed the population of the Republic of Ireland was 5,149,000, a 31 per cent increase from 2002. In May the CSO released findings on the number of births and deaths recorded in Ireland during 2024 which showed the national fertility rate to be 1.5, a decrease of 0.4 from 2014. 'A value of 2.1 is generally considered to be the level at which the population would replace itself in the long run, ignoring migration,' the CSO said. The CSO findings also showed that the rates of deaths related to tumours and cancers were highest in Tralee, Co Kerry, Swinford, Co Mayo and Roscrea-Templemore, Co Tipperary. Deaths caused by respiratory diseases such as influenza, pneumonia and bronchitis were most common in Manorhamilton, Co Leitrim, Ballinasloe, Co Galway and Enniscorthy, Co Wexford.


Irish Times
17 hours ago
- Irish Times
Agency nurse's two complaints alleging penalisation rejected by Labour Court
An agency nurse working in intellectual disability residential services who reported a staff colleague for pouring water over a patient has had two complaints alleging penalisation in the aftermath of the incident rejected by the Labour Court . Gerard Foy appealed decisions by an adjudication officer at the Workplace Relations Commission where it was found, while he had made a valid protected disclosure in respect of the incident, he had failed to establish this had directly led to him failing to secure staff jobs he applied for or to the reduction of his hours as an agency nurse. At the Labour Court hearing, the HSE acknowledged the incident Mr Foy witnessed in April 2020, which was the pouring of a cup of water over a patient by a female colleague who was directly employed at the facility, amounted to an assault. It said he followed all the correct procedures in the way he reported the incident to management, but breached GDPR guidelines by also reporting it to two other colleagues coming on duty at the end of his shift. READ MORE Mr Foy said he was told by his line manager if it had been a staff member who had witnessed the incident it would not have been reported. Despite this, he said he believed the incident had not initially caused him any problems in his work and the person who he had reported apologised to him for putting him a difficult position. This changed over time, he suggested, and he began to feel colleagues turned against him. In January and February 2022 he applied for staff nurse roles he felt he was more than qualified for but failed to secure the positions. He said they went to far less experienced candidates. He appealed the outcome but an initial investigation upheld the decision of the interview panel and he did not take the matter further. He began to get fewer hours, however, and fewer premium shifts. He said he was told this was in part because the colleague he reported, who had been moved to a different area of the facility but was employed there, said she did not want him rostered to work with her and this was facilitated by senior management. The HSE said because other staff positions were filled, there was less need for agency staff. Mr Foy wrote to the regional director of nursing for the area, Eva Hayes, to say he felt unsupported by management in the wake of the incident. Mr Foy said he met Ms Hayes to discuss the situation in October 2022 when he was surprised by the weight attached to the GDPR issue. He was, he told the court, pressured to apologise for the privacy breach to the staff member he had reported and, fearing he would lose more work, had to agree to undertake GDPR training. The apology he subsequently made to the colleague was in writing because she would not deal directly with him. He said he felt 'isolated, bullied, victimised and punished' because he had acted properly. The HSE said the incident had been fully dealt with in a confidential process and he had been treated fairly at all times. The court found he had made a protected disclosure but agreed with the WRC that he had failed to establish a direct link between his report of wrongdoing and his subsequent failure in the recruitment process or what he regarded as other examples of penalisation. It also said he had failed to prove penalisation during the six-month period it had jurisdiction to consider and the WRC's decision that his two complaints were not well founded was upheld.